UBS Group
PRLB icon

UBS Group’s Protolabs PRLB Stock Holding History

UBS Group’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,500
Closed -$745K – 7890
2016
Q4 		$745K Sell
14,500
-45,500
-76% -$2.39M ﹤0.01% 3804
2016
Q3 		$3.6M Buy
+60,000
New +$3.45M ﹤0.01% 2327

Other funds holding PRLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

UBS Group's PRLB Position: Q1 2026 in Review

UBS Group reduced its Protolabs (PRLB) stake by 3.8% in Q1 2026, selling an estimated $387K and leaving 168,750 shares worth $9.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3396.

UBS Group first reported a position in PRLB in Q4 2014 and has held it in 46 quarters since. The position peaked at $9.68M in Q2 2025. 262 funds tracked by Wall St. Rank hold PRLB as of Q1 2026.

  • UBS Group held 168,750 shares of Protolabs worth $9.62M as of Q1 2026.
  • UBS Group sold 6,666 Protolabs shares in Q1 2026, an estimated $387K.
  • Protolabs made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3396 holding.
  • UBS Group first reported a position in Protolabs in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Protolabs position peaked at $9.68M in Q2 2025.
  • 262 funds tracked by Wall St. Rank held Protolabs as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.